PF-07307405

Vaccine

Phase 3Mechanism not established
Phase 3underway

Evidence outlook · registrational

Lyme Disease: registrational readout pending

No completed mid-stage readout is on record. Registrational readout expected around 2026-12-04.

How the evidence outlook works ↗

All registered studies

Every ClinicalTrials.gov study of this drug's own program. Studies backing a featured trial above are marked Featured; the rest aren't individually graded. Filter by which indication a study was run for, then browse by phase.

Phase 3 (4)
Lyme Disease
NCT07226882 · Pfizer
2025-11-19 – 2028-01-27 · Lyme Borreliosis
What this study did
NCT07500506 · Pfizer
2026-04-08 – 2026-12-04 · Lyme Disease
What this study did
NCT05634811 · Pfizer
2022-12-12 – 2025-07-21 · Lyme Disease
What this study did
Phase 2 (3)
Other / comorbidity
NCT04801420 · Pfizer
2021-03-08 – 2025-07-02 · Lyme Borreliosis
What this study did
NCT03970733 · Pfizer
2019-07-01 – 2022-03-28 · Lyme Borreliosis
What this study did
Phase 1 (1)
Other / comorbidity
NCT03010228 · Pfizer
2017-01-31 – 2019-01-16 · Lyme Borreliosis, Nervous System
What this study did

Competitive landscape

No competitors sharing a mechanism or indication in the current universe.

Upcoming events

(2 total)

Estimated primary-completion dates from ClinicalTrials.gov. These are registry estimates, never confirmed readout dates; they can move as trials progress.

Follow PF-07307405 to get an email as a readout nears, when a date moves, or when a study changes status. Needs a free account.

Add these readouts to your calendar: Apple or Outlook · Google Calendar · .ics link. The calendar updates when a registry date moves.

2026 (1)
December 2026 (1)
Phase 3Lyme DiseaseRecruiting
Est. primary completion 2026-12-04 · NCT07500506 · CT.gov ↗
What to watch
2028 (1)
January 2028 (1)
Phase 3Lyme DiseaseActive not recruiting
Est. primary completion 2028-01-27 · NCT07226882 · CT.gov ↗
What to watch

See the full readout calendar ↗